Ansell Ltd
ASX:ANN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Ansell Ltd
Total Liabilities & Equity
Ansell Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Ansell Ltd
ASX:ANN
|
Total Liabilities & Equity
$3.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
|
Nanosonics Ltd
ASX:NAN
|
Total Liabilities & Equity
AU$279.3m
|
CAGR 3-Years
11%
|
CAGR 5-Years
13%
|
CAGR 10-Years
17%
|
|
|
Polynovo Ltd
ASX:PNV
|
Total Liabilities & Equity
AU$123.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
28%
|
CAGR 10-Years
21%
|
|
|
SDI Ltd
ASX:SDI
|
Total Liabilities & Equity
AU$135.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
|
Anteris Technologies Ltd
ASX:AVR
|
Total Liabilities & Equity
AU$23m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lumos Diagnostics Holdings Ltd
ASX:LDX
|
Total Liabilities & Equity
$20.8m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
Ansell Ltd
Glance View
Ansell Ltd, with its origins tracing back to the innovative entrepreneurship of founder Eric Norman Ansell in the early 20th century, has established itself as a global leader in protection solutions. Initially starting with condoms and expanding into gloves, the company now boasts a diversified portfolio encompassing protective solutions for industrial workers and healthcare professionals. This growth reflects Ansell's adept ability to identify and respond to evolving market demands. The company has capitalized on its deep expertise in material science and product design, underpinning its operations with a robust research and development framework that continually pushes the boundaries of product efficacy and safety. Instrumental to its business model is Ansell’s alignment with regulatory standards across its wide geographical footprint, ensuring that its products not only meet but often exceed industry and safety specifications. By navigating complex regulations and maintaining high standards, Ansell has cemented relationships with a broad clientele base drawn from healthcare providers, industrial entities, and retail channels. The company thrives by leveraging its extensive distribution network and strategic acquisitions, enhancing its global presence. Through innovative product lines, such as cut-protection gloves and surgical solutions, Ansell generates revenue by addressing critical safety needs, ensuring that both individuals and organizations can rely on its products to protect them in the most demanding environments.
See Also
What is Ansell Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
3.3B
USD
Based on the financial report for Dec 31, 2025, Ansell Ltd's Total Liabilities & Equity amounts to 3.3B USD.
What is Ansell Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
4%
Over the last year, the Total Liabilities & Equity growth was 2%. The average annual Total Liabilities & Equity growth rates for Ansell Ltd have been 9% over the past three years , 5% over the past five years , and 4% over the past ten years .